809 related articles for article (PubMed ID: 26847689)
1. The paradoxical psychological effects of lysergic acid diethylamide (LSD).
Carhart-Harris RL; Kaelen M; Bolstridge M; Williams TM; Williams LT; Underwood R; Feilding A; Nutt DJ
Psychol Med; 2016 May; 46(7):1379-90. PubMed ID: 26847689
[TBL] [Abstract][Full Text] [Related]
2. Role of the 5-HT
Preller KH; Schilbach L; Pokorny T; Flemming J; Seifritz E; Vollenweider FX
J Neurosci; 2018 Apr; 38(14):3603-3611. PubMed ID: 29555857
[TBL] [Abstract][Full Text] [Related]
3. Long-lasting subjective effects of LSD in normal subjects.
Schmid Y; Liechti ME
Psychopharmacology (Berl); 2018 Feb; 235(2):535-545. PubMed ID: 28918441
[TBL] [Abstract][Full Text] [Related]
4. Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study.
Hutten NRPW; Mason NL; Dolder PC; Theunissen EL; Holze F; Liechti ME; Feilding A; Ramaekers JG; Kuypers KPC
Eur Neuropsychopharmacol; 2020 Dec; 41():81-91. PubMed ID: 33082016
[TBL] [Abstract][Full Text] [Related]
5. Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects.
Schmid Y; Enzler F; Gasser P; Grouzmann E; Preller KH; Vollenweider FX; Brenneisen R; Müller F; Borgwardt S; Liechti ME
Biol Psychiatry; 2015 Oct; 78(8):544-53. PubMed ID: 25575620
[TBL] [Abstract][Full Text] [Related]
6. Acute Effects of Lysergic Acid Diethylamide on Circulating Steroid Levels in Healthy Subjects.
Strajhar P; Schmid Y; Liakoni E; Dolder PC; Rentsch KM; Kratschmar DV; Odermatt A; Liechti ME
J Neuroendocrinol; 2016 Mar; 28(3):12374. PubMed ID: 26849997
[TBL] [Abstract][Full Text] [Related]
7. Effective connectivity changes in LSD-induced altered states of consciousness in humans.
Preller KH; Razi A; Zeidman P; Stämpfli P; Friston KJ; Vollenweider FX
Proc Natl Acad Sci U S A; 2019 Feb; 116(7):2743-2748. PubMed ID: 30692255
[TBL] [Abstract][Full Text] [Related]
8. Acute Subjective and Behavioral Effects of Microdoses of Lysergic Acid Diethylamide in Healthy Human Volunteers.
Bershad AK; Schepers ST; Bremmer MP; Lee R; de Wit H
Biol Psychiatry; 2019 Nov; 86(10):792-800. PubMed ID: 31331617
[TBL] [Abstract][Full Text] [Related]
9. Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD).
Brandt SD; Kavanagh PV; Westphal F; Stratford A; Elliott SP; Hoang K; Wallach J; Halberstadt AL
Drug Test Anal; 2016 Sep; 8(9):891-902. PubMed ID: 26456305
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects.
Dolder PC; Schmid Y; Steuer AE; Kraemer T; Rentsch KM; Hammann F; Liechti ME
Clin Pharmacokinet; 2017 Oct; 56(10):1219-1230. PubMed ID: 28197931
[TBL] [Abstract][Full Text] [Related]
11. Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor.
Preller KH; Burt JB; Ji JL; Schleifer CH; Adkinson BD; Stämpfli P; Seifritz E; Repovs G; Krystal JH; Murray JD; Vollenweider FX; Anticevic A
Elife; 2018 Oct; 7():. PubMed ID: 30355445
[TBL] [Abstract][Full Text] [Related]
12. Greater subjective effects of a low dose of LSD in participants with depressed mood.
Molla H; Lee R; Tare I; de Wit H
Neuropsychopharmacology; 2024 Apr; 49(5):774-781. PubMed ID: 38042914
[TBL] [Abstract][Full Text] [Related]
13. Tolerance to LSD and DOB induced shaking behaviour: differential adaptations of frontocortical 5-HT(2A) and glutamate receptor binding sites.
Buchborn T; Schröder H; Dieterich DC; Grecksch G; Höllt V
Behav Brain Res; 2015 Mar; 281():62-8. PubMed ID: 25513973
[TBL] [Abstract][Full Text] [Related]
14. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex.
Gresch PJ; Smith RL; Barrett RJ; Sanders-Bush E
Neuropsychopharmacology; 2005 Sep; 30(9):1693-702. PubMed ID: 15756304
[TBL] [Abstract][Full Text] [Related]
15. The effects of Lysergic Acid Diethylamide (LSD) on the Positive Valence Systems: A Research Domain Criteria (RDoC)-Informed Systematic Review.
Pouyan N; Younesi Sisi F; Kargar A; Scheidegger M; McIntyre RS; Morrow JD
CNS Drugs; 2023 Dec; 37(12):1027-1063. PubMed ID: 37999867
[TBL] [Abstract][Full Text] [Related]
16. Intrahippocampal LSD accelerates learning and desensitizes the 5-HT(2A) receptor in the rabbit, Romano et al.
Romano AG; Quinn JL; Li L; Dave KD; Schindler EA; Aloyo VJ; Harvey JA
Psychopharmacology (Berl); 2010 Oct; 212(3):441-8. PubMed ID: 20827462
[TBL] [Abstract][Full Text] [Related]
17. Hallucinogens and Serotonin 5-HT
López-Giménez JF; González-Maeso J
Curr Top Behav Neurosci; 2018; 36():45-73. PubMed ID: 28677096
[TBL] [Abstract][Full Text] [Related]
18. LSD-induced entropic brain activity predicts subsequent personality change.
Lebedev AV; Kaelen M; Lövdén M; Nilsson J; Feilding A; Nutt DJ; Carhart-Harris RL
Hum Brain Mapp; 2016 Sep; 37(9):3203-13. PubMed ID: 27151536
[TBL] [Abstract][Full Text] [Related]
19. Serotonin type 5A receptor antagonists inhibit D-lysergic acid diethylamide discriminatory cue in rats.
Popik P; Krawczyk M; Kuziak A; Bugno R; Hogendorf A; Staroń J; Nikiforuk A
J Psychopharmacol; 2019 Nov; 33(11):1447-1455. PubMed ID: 31452444
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide Microdoses in Healthy Participants.
Holze F; Liechti ME; Hutten NRPW; Mason NL; Dolder PC; Theunissen EL; Duthaler U; Feilding A; Ramaekers JG; Kuypers KPC
Clin Pharmacol Ther; 2021 Mar; 109(3):658-666. PubMed ID: 32975835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
